The etiology of many chronic diseases involves interactions between environmental factors and genes that regulate important physiological processes. 1 These complex interactions define the field of toxicogenomics. Several major challenges include elucidating the molecular mechanisms of action of environmental chemicals, developing methods to predict toxicity effectively and understanding the genetic basis of differential susceptibility. The Comparative Toxicogenomics Database (CTD) 2 is being developed to help meet these challenges by facilitating comparative studies of toxicologically significant genes and proteins across diverse species.
Genome-sequencing projects have led to a new way of thinking in biology, and promise to effect a better understanding of disease-associated genes. 3 Our understanding of the sequence and its value, however, is limited by our ability to annotate and retrieve meaning from it. 4 The human genome and other sequencing projects have underscored our increasing reliance on bioinformatics resources and interspecies comparative sequence analysis. These comparative analyses provide insight into molecular and genomic evolution, contribute to the identification of conserved sequences and facilitate predictions of functionally significant sequences in both regulatory and coding regions. 5, 6 Initial comparative analysis of the mouse and human genomes identified orthologous genes, polymorphisms and the extent of sequence similarity and synteny between the species. 7 Comparative studies that include evolutionarily diverse sequences may further enhance the identification of coding and regulatory regions that might explain tissue-, developmentand species-specific function and expression patterns. 6 Evolutionary distance may also help to distinguish between conserved sequences that are functionally significant and those that simply lack divergence time, particularly for genes that have evolved more slowly. 5 The value of this approach was demonstrated by comparative studies with the pufferfish genomic sequence, which led to the discovery of nearly 1000 human genes not previously described in the public domain. 3 The exponential rise in the amount of available sequence data has stimulated the development of specialized, curated databases. Despite the increasing number of databases, limitations to accessing molecular toxicology information persist primarily because of a lack of integration and curation of data specific to toxicogenomics. Several new resources under development may resolve some of these limitations by addressing different, but complementary, aspects of toxicogenomics and pharmacogenomics. These resources include CTD 2 , the Chemical Effects in Biological Systems (CEBS) 8 and the PharmGKB database. 9 CTD will be the first publicly available, curated database devoted to genes and proteins of human toxicological significance. The major goals of this resource include: (1) curating and integrating sequence, reference and toxicant data for toxicologically important genes and proteins; (2) promoting comparative studies of these genes and proteins across evolutionarily diverse organisms and (3) integrating information from existing molecular and toxicology resources. CTD is being developed at the Mount Desert Island Biological Laboratory with support by NIEHS and in collaboration with investigators from other NIEHS Marine and Freshwater Biomedical Sciences (MFBS) Centers and other research institutions.
The major categories of data in CTD include molecular sequences, references, toxicants, taxonomy, genes, gene synonyms and Gene Sets. All nucleotide sequences are acquired from the National Center for Biotechnology Information (NCBI; Figure 1a ). Nonredundant nucleotide (RefSeq) sequences are the only nucleotide sequences included for Homo sapiens, Mus musculus, Rattus norvegicus, Drosophila melanogaster and Caenorhabditis elegans, whereas all GenBank and RefSeq nucleotide sequences are included for all other vertebrates and invertebrates. 10, 11 Amino-acid sequences for vertebrates and invertebrates are acquired from the Swiss-Prot and TrEMBL databases at the European Bioinformatics Institute (EBI). 12 References are acquired from PubMed at NCBI.
A controlled vocabulary for substances and toxicants has been integrated with CTD, and consists of a modified subset of descriptors from the 'Chemicals and Drugs' category and Supplementary Concept Records (chemicals) from the Medical Subject Headings (MeSH) database developed at the National Library of Medicine (NLM; Figure 1a) . 13 This vocabulary assists users by accounting for synonyms of substances and chemicals, and its hierarchical structure permits users to query using specific (eg, 'copper') or broad terms (eg, 'heavy metals'). It will also be used to expand the toxicological annotation in CTD through automated queries that identify and assign chemical and substance terms to sequences and references. Similarly, the NCBI Taxonomy database has been integrated with CTD, permitting users to query with scientific (eg, Danio rerio) or common (eg, zebrafish) names, as well as broader taxonomic terms (eg, teleostei). The current focus of curation and integration efforts for CTD is to create explicit associations among nucleotide and amino-acid sequences, references and toxicants, as well as between sequences and genes, through the construction of Gene Sets (Figure 1b) . Relationships between sequences and genes are created automatically using sequence record annotation; these relationships mark a significant departure from many molecular databases that represent sequences in isolation. A Gene Set is a CTD-curated group of nucleotide and amino-acid sequences from diverse species for a gene or related genes. Genes are assigned to Gene Sets using complex regular expressions (search patterns) that are matched against gene names, symbols and synonyms. A Gene Set provides a text description, a list of member genes, a comprehensive group of synonyms for each gene and all toxicants and sequences associated with each member gene in a given organism. Gene Sets provide users with a comprehensive, comparative view of the available sequences for toxicologically relevant genes, and will facilitate comparison of sequences across species. These comparisons may promote a better understanding of molecular evolution, the significance of conserved sequences and the genetic basis of variable susceptibility. Priority for Gene Set curation is determined using the 554 genes identified as environmentally responsive by the NIEHS Environmental Genome Project. 14 Data in CTD are highly integrated, allowing users to search CTD by terms from a variety of other resources including the Swiss-Prot and TrEMBL databases at EBI, and the GenBank, RefSeq, MeSH, Taxonomy and PubMed databases at NCBI. Uniquely, this integration allows for simultaneous searching of nucleotide and protein sequences. CTD also provides hypertext crossreferences from individual sequences and references to numerous external biological databases. Toxicology resources (eg, TOXNET) are the next priority for database integration. Sequences are ordered by the Gene Set to which they were assigned in CTD, the CTD-curated gene symbol, organism from which the sequence was cloned, molecule type, accession ID and the description of the sequence from the source database. All toxicants or substances associated with a resulting gene are noted by the organism.
To our knowledge, this will be the first publicly available effort to integrate data from molecular and toxicology resources.
A prototype user interface for CTD has been developed and includes: a home page; reference and comparative sequence query forms; a list of Gene Sets; Gene Set, sequence and reference detail pages; help pages; access to additional resources for sequences and references; and mechanisms for users to provide CTD staff with feedback. Reference and comparative sequence query forms allow users to search for references and sequences, respectively, by a range of criteria including a gene name or symbol, a specific substance/toxicant or classification of substances/toxicants, a vertebrate or invertebrate taxon and author (Figure 2a) . Query results are presented in a summary format, permitting users to evaluate and choose results of interest. Specifically, a comparative sequence summary presents information for each matching sequence organized by the associated Gene Set, and then by gene, organism, description and substances/toxicants (Figure 2b) . From summary pages, users may navigate to more detailed information about individual sequences, Gene Sets or references.
Beyond facilitating access to toxicological information, CTD also enhances access to basic molecular data by virtue of the data structure and integration. This enhanced access has implications for the broader biological and clinical communities. For example, the following queries are directly supported by CTD: In which organisms has a particular gene been cloned? In which articles was a particular gene studied? Which genes and/ or sequences have been studied by a particular author? Which genes and/or sequences have been studied with a specific substance (eg clinical drug)? Other examples include the use of gene synonyms, which allows users to query for data by a range of gene names or symbols and the ability to navigate between related sequences.
The content and functionality of CTD will continue to expand based on the needs of the biological and toxicological communities. This expansion may include enhancing the scope of manual curation, integrating comparative analysis results with curated data and integrating toxicological microarray data from aquatic animals. Expansion will be facilitated by the flexibility of CTD's data model and by the nature of the data being curated, which is independent of any particular scientific technology. As genomic knowledge and biological techniques advance, there will be significant opportunities to further promote comparative studies and enhance the depth of curation of toxicologically significant genes.
CTD is currently being reviewed internally by collaborating investigators. To ensure that it becomes a valuable resource for the scientific community, we invite participation in its development (ctd@mdibl.org).
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